Combining methylated RNF180 and SFRP2 plasma biomarkers for noninvasive diagnosis of gastric cancer
Our results suggest that RNF180 and SFRP2 could serve as diagnostic biomarkers for GC when using the RF model.
Authors
- Hao Zou (ORCID: https://orcid.org/0000-0001-9140-418X)
- Jihong Zhu (ORCID: https://orcid.org/0000-0001-8884-0298)
- Dong Wang (ORCID: https://orcid.org/0000-0003-4278-2728)
- Yanru Feng (ORCID: https://orcid.org/0000-0001-6364-8400)
- Zhihao Dai
- Jin Jiang (ORCID: https://orcid.org/0000-0002-3301-2759)
- Qianping Chen
- Tong Zhang (ORCID: https://orcid.org/0000-0002-2046-4502)
- Minghua Bai
- Litheng Ng
- Jun Zheng (ORCID: https://orcid.org/0000-0001-9532-3301)
- Wei Mao (ORCID: https://orcid.org/0000-0003-4741-4094)
- Quanquan Sun
- Dong Liu (ORCID: https://orcid.org/0000-0001-6600-0730)
- Liang Han (ORCID: https://orcid.org/0000-0003-1081-0077)
Institutions
- Zhejiang Cancer Hospital (CN)
- First Hospital of Jiaxing (CN)
- CS Diagnostics (DE)
- Hangzhou Cancer Hospital (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1016/j.tranon.2024.102190
- Citations
- 5
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- National Health Commission of the People's Republic of China